What is the history of Genmab?
Genmab was founded as an independent company in Copenhagen in February 1999. Within its first year and a half of existence, Genmab raised approximately USD 60 million, including a USD 40.5 million private placement, at the time the largest offering ever by a private European biotechnology company. This offering was led by Geneva-based Index Ventures and included new investors Apax Europe IV and Lombard Odier Immunology Fund, as well as BankInvest, Medarex, Inc., Lønmodtagernes Dyrtidsfond and A/S Dansk Erhvervsinvestering. In October 2000, Genmab announced listings on the Copenhagen Stock Exchange (now the NASDAQ OMX Copenhagen A/S) and the Frankfurt Stock Exchange, with a Global Offering that raised DKK 1.56 billion (approximately USD 183 million), the largest European biotech IPO at the time. Genmab remains one of the best-funded European biotechnology companies. In June of 2002, Genmab received a USD 20 million (approximately DKK 170 million) equity investment from Roche in connecti
